| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.54 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |